18.300USD+18.300After-hours 08/03, 20:00 (ET)
368.70MMarket Cap
LossP/E TTM
Key Figures
18.310Open
18.340High
377.98KVolume
LossP/E TTM
31.96P/E Dynamic
--Dividend TTM
1.87%Turnover Ratio
18.300Prev. Close
18.220Low
4.59MTurnover
LossP/E Static
2.65P/B
0.00%Div Yield TTM
-36.09%ROA
32.51552wk High
1.27Volume Ratio
-64.72MNet Profit
20.22MShares
-3.1244EPS TTM
1.31Beta
-38.84%ROE
11.09052wk Low
0.66%Amplitude
65.27%Gross Margin
368.70MMarket Cap
-0.10Reward/Risk
3.14%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Simulations Plus Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 104 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 19.83.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Simulations Plus Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Simulations Plus Inc Highlights
StrengthsRisks
Simulations Plus Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Simulations Plus Inc Info
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Ticker SymbolSLP
CompanySimulations Plus Inc
CEOO'Connor (Shawn M)
Websitehttps://www.simulations-plus.com/
Shareholders
FAQs
What is the current price of Simulations Plus Inc (SLP)?
The current price of Simulations Plus Inc (SLP) is 18.23.
What is the symbol of Simulations Plus Inc?
The ticker symbol of Simulations Plus Inc is SLP.
What is the 52-week high of Simulations Plus Inc?
The 52-week high of Simulations Plus Inc is 32.52.
What is the 52-week low of Simulations Plus Inc?
The 52-week low of Simulations Plus Inc is 11.09.
What is the market capitalization of Simulations Plus Inc?
The market capitalization of Simulations Plus Inc is 368.70M.
Is Simulations Plus Inc (SLP) currently rated as Buy, Hold, or Sell?
According to analysts, Simulations Plus Inc (SLP) has an overall rating of signal_hold, with a price target of 19.83.
What is the Earnings Per Share (EPS TTM) of Simulations Plus Inc (SLP)?
The Earnings Per Share (EPS TTM) of Simulations Plus Inc (SLP) is -3.22.
